Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

University of Toronto

$120,000.00

Investigating the role of NDPK in beta cell function and the pathogenesis of Type 1 Diabetes (T1D)

FY 2025-26

Summary
In the human body, organs communicate with each other through hormones. One of the most important is insulin, made by specialized beta cells in the pancreas. Insulin tells fat, muscle, and liver cells to absorb sugar from the blood, which provides energy and keeps blood sugar levels in balance. In type 1 diabetes (T1D), the immune system destroys beta cells, leaving the body without enough insulin to control blood sugar. Once T1D is diagnosed it is a life-long disease with no cure. Recent research shows that diabetes begins before beta cells are destroyed, due to problems in how organs respond to insulin and subsequently communicate back to the pancreas. A newly discovered hormone complex, called Fabkin, is secreted by fat cells before diabetes is diagnosed and influences the health of beta cells. In mouse studies, blocking Fabkin helped beta cells stay healthier, produce more insulin, and prevented T1D. Our project builds on this discovery by focusing on one key component of Fabkin, called NDPK. We will study how exactly NDPK affects beta cell survival and function, and test whether targeting NDPK directly with small molecules can prevent or delay T1D in mice. If successful, this work could lay the foundation for a new approach to preventing diabetes by protecting beta cells before they are damaged or lost. This would improve personal health by offering new ways to delay or avoid insulin injections, reduce complications, and support long-term well-being. At a population level, preventing or delaying T1D would lower healthcare costs and improve quality of life for thousands of Canadians and millions worldwide. By uncovering new biology and therapeutic targets, this research could also accelerate the development of better treatments and strengthen the healthcare system's ability to manage diabetes.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
559717
Name
Luo Yihan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating the role of NDPK in beta cell function and the pathogenesis of Type 1 Diabetes (T1D)
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cell And Animal Models; Human Islets; Islets Function And Inter-Organ Communications; Live Cell Assays And Imaging; Molecular Assays; Multi-Omics And Bioinformatics; Ndpk; Rna Sequencing; Small Molecules; Type 1 Diabetes
Abstract
In the human body, organs communicate with each other through hormones. One of the most important is insulin, made by specialized beta cells in the pancreas. Insulin tells fat, muscle, and liver cells to absorb sugar from the blood, which provides energy and keeps blood sugar levels in balance. In type 1 diabetes (T1D), the immune system destroys beta cells, leaving the body without enough insulin to control blood sugar. Once T1D is diagnosed it is a life-long disease with no cure. Recent research shows that diabetes begins before beta cells are destroyed, due to problems in how organs respond to insulin and subsequently communicate back to the pancreas. A newly discovered hormone complex, called Fabkin, is secreted by fat cells before diabetes is diagnosed and influences the health of beta cells. In mouse studies, blocking Fabkin helped beta cells stay healthier, produce more insulin, and prevented T1D. Our project builds on this discovery by focusing on one key component of Fabkin, called NDPK. We will study how exactly NDPK affects beta cell survival and function, and test whether targeting NDPK directly with small molecules can prevent or delay T1D in mice. If successful, this work could lay the foundation for a new approach to preventing diabetes by protecting beta cells before they are damaged or lost. This would improve personal health by offering new ways to delay or avoid insulin injections, reduce complications, and support long-term well-being. At a population level, preventing or delaying T1D would lower healthcare costs and improve quality of life for thousands of Canadians and millions worldwide. By uncovering new biology and therapeutic targets, this research could also accelerate the development of better treatments and strengthen the healthcare system's ability to manage diabetes.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Luo, Yihan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~